Country
Drug factories in Sweden
11 plants in Sweden are named on current U.S. prescription drug labels. FDA has inspected 11 of them; 1 had serious problems at their last inspection.
| Plant | City | Products | Last FDA inspection |
|---|---|---|---|
| Pfizer Health AB | Strangnas | 23 | Problems found, fixed voluntarilyMar 2026 |
| Fresenius Kabi AB | Uppsala | 16 | Problems found, fixed voluntarilyJan 2025 |
| AstraZeneca AB | Sodertalje | 15 | Problems found, fixed voluntarilyDec 2025 |
| Rechon Life Science AB | Limhamn | 14 | Serious problems, FDA actionSep 2024 |
| Cambrex Karlskoga AB | Karlskoga | 9 | Problems found, fixed voluntarilyMay 2024 |
| Apotek Produktion & Laboratorier AB | Kungens Kurva | 4 | No problems foundApr 2022 |
| PolyPeptide Laboratories (Sweden) AB | Limhamn | 2 | Problems found, fixed voluntarilyJan 2025 |
| QPharma AB | Malmo | 2 | Problems found, fixed voluntarilyMay 2023 |
| Eurofins BioPharma Product Testing Sweden AB | Uppsala | 1 | Problems found, fixed voluntarilyJun 2024 |
| Meribel Pharma Karlskoga AB | Karlskoga | 1 | Problems found, fixed voluntarilyAug 2025 |
| Mikrolab Stockholm AB | Sollentuna | 1 | Problems found, fixed voluntarilyMar 2025 |